CN103463596B - A kind of sweat gland mediates the external used medicine for the treatment of gout and rheumatism - Google Patents
A kind of sweat gland mediates the external used medicine for the treatment of gout and rheumatism Download PDFInfo
- Publication number
- CN103463596B CN103463596B CN201310389781.3A CN201310389781A CN103463596B CN 103463596 B CN103463596 B CN 103463596B CN 201310389781 A CN201310389781 A CN 201310389781A CN 103463596 B CN103463596 B CN 103463596B
- Authority
- CN
- China
- Prior art keywords
- gout
- weight ratio
- rheumatism
- rhizoma zingiberis
- pericarpium zanthoxyli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 72
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 210000000106 sweat gland Anatomy 0.000 title claims abstract description 41
- 150000003839 salts Chemical class 0.000 claims abstract description 53
- 239000008187 granular material Substances 0.000 claims abstract description 43
- 241000628997 Flos Species 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 15
- 239000011858 nanopowder Substances 0.000 claims description 9
- 238000004806 packaging method and process Methods 0.000 claims description 9
- 239000011505 plaster Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000498 ball milling Methods 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000004088 foaming agent Substances 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 22
- 201000010099 disease Diseases 0.000 abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 22
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 17
- 229940116269 uric acid Drugs 0.000 abstract description 16
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 15
- 241000283707 Capra Species 0.000 abstract description 9
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 201000004624 Dermatitis Diseases 0.000 abstract description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 abstract description 4
- 208000010668 atopic eczema Diseases 0.000 abstract description 4
- 208000002894 beriberi Diseases 0.000 abstract description 4
- 201000008482 osteoarthritis Diseases 0.000 abstract description 4
- 244000052769 pathogen Species 0.000 abstract description 3
- 230000004144 purine metabolism Effects 0.000 abstract description 3
- 235000014347 soups Nutrition 0.000 abstract description 3
- 208000010195 Onychomycosis Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 239000002207 metabolite Substances 0.000 abstract description 2
- 201000005882 tinea unguium Diseases 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 24
- 230000036407 pain Effects 0.000 description 24
- 210000002683 foot Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000002574 poison Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 235000010894 Artemisia argyi Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 244000030166 artemisia Species 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- -1 92768 milligrams Chemical compound 0.000 description 2
- 206010029240 Neuritis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 229940098330 gamma linoleic acid Drugs 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000021167 banquet Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000003483 hypokinetic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical compound [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000003339 pneumostatic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310389781.3A CN103463596B (en) | 2013-09-02 | 2013-09-02 | A kind of sweat gland mediates the external used medicine for the treatment of gout and rheumatism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310389781.3A CN103463596B (en) | 2013-09-02 | 2013-09-02 | A kind of sweat gland mediates the external used medicine for the treatment of gout and rheumatism |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103463596A CN103463596A (en) | 2013-12-25 |
CN103463596B true CN103463596B (en) | 2016-04-13 |
Family
ID=49788787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310389781.3A Active CN103463596B (en) | 2013-09-02 | 2013-09-02 | A kind of sweat gland mediates the external used medicine for the treatment of gout and rheumatism |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103463596B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634384A (en) * | 2004-11-02 | 2005-07-06 | 苗丽健 | Externally used washing lotion and preparation method thereof |
CN101618004A (en) * | 2009-07-09 | 2010-01-06 | 郭志忠 | Chinese herbal medicine bag for foot bath for promoting blood circulation, relaxing muscles and tendons, dredging collaterals and relieving pain |
CN102085339A (en) * | 2009-12-06 | 2011-06-08 | 雪莲 | Tibetan medicine for treating cervical spondylosis |
-
2013
- 2013-09-02 CN CN201310389781.3A patent/CN103463596B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634384A (en) * | 2004-11-02 | 2005-07-06 | 苗丽健 | Externally used washing lotion and preparation method thereof |
CN101618004A (en) * | 2009-07-09 | 2010-01-06 | 郭志忠 | Chinese herbal medicine bag for foot bath for promoting blood circulation, relaxing muscles and tendons, dredging collaterals and relieving pain |
CN102085339A (en) * | 2009-12-06 | 2011-06-08 | 雪莲 | Tibetan medicine for treating cervical spondylosis |
Also Published As
Publication number | Publication date |
---|---|
CN103463596A (en) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
CN103656238B (en) | A kind of Chinese medicine composition for the treatment of rheumatic osteopathia | |
CN102327420B (en) | Chinese medicinal composition for setting bones and replenishing muscles and ligaments | |
CN104147577B (en) | A kind of plaster for promoting growth of spur to treat fracture | |
CN102319332B (en) | Musk bone reunion Chinese medicinal composition | |
CN101062377B (en) | Adhesive plaster for diminishing inflammation, expelling wind and cold | |
CN1413627A (en) | Medicine for treating dematosis | |
CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
CN102078527A (en) | Traditional Chinese medicine formula for treating urinary calculus | |
CN105770835A (en) | Medicated wine for treating rheumatism and bone diseases and capable of tonifying kidney and strengthening yang and production method thereof | |
CN103285206B (en) | Traditional Chinese medicinal liquor for treating rheumatic arthritis | |
CN103736069A (en) | Plaster for treating rheumatism and preparation method thereof | |
CN103463597B (en) | A kind of health medicine for the treatment of gout | |
CN105031408A (en) | Health product for improving gout | |
CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
CN101904958B (en) | Oral medicinal composition for treating fracture | |
CN103463596B (en) | A kind of sweat gland mediates the external used medicine for the treatment of gout and rheumatism | |
CN102512560A (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
CN104398649A (en) | Medicinal oil for treating burn and scald and preparation method thereof | |
CN104352907A (en) | Traditional Chinese medicine composition for treating chronic gouty arthritis | |
CN104127636A (en) | Traditional Chinese medicine composition for treating gout disease | |
CN104606395A (en) | Traditional Chinese medicine prescription treating menstrual fever | |
CN105381168B (en) | A kind of Yaotongning medicine and preparation method thereof | |
CN107929636A (en) | A kind of Traditional Chinese medicinal spray for treating pain and preparation method thereof | |
CN105832934A (en) | Traditional Chinese medicine for treating hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151209 Address after: 750021 office building, 80 Guang Shun Road, Xixia District, the Ningxia Hui Autonomous Region, Yinchuan Applicant after: Zhang Wenju Address before: 750001 room 2-602, building, center lane, Xingqing District, the Ningxia Hui Autonomous Region, Yinchuan Applicant before: Zhang Wenju |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191031 Address after: 750409 business room 24, 25 and 30, jinpingge commercial street, Ningdong Town, Lingwu City, Yinchuan City, Ningxia Hui Autonomous Region Patentee after: Ningxia borderless intellectual property operation management Co., Ltd Address before: 750021 office building, 80 Guang Shun Road, Xixia District, the Ningxia Hui Autonomous Region, Yinchuan Patentee before: Zhang Wenju |
|
TR01 | Transfer of patent right |